The FXIII Val 34 Leu Mutation and the Risk of Venous Thrombosis

Martine Alhenc-Gelas; Jean-Luc Reny; Marie-Laurence Aubry; Martine Aiach; Joseph Emmerich

doi:10.1055/s-0037-1614180

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2000; 84(06): 1117-1118
DOI: 10.1055/s-0037-1614180

Letters to the Editor

Schattauer GmbH

The FXIII Val 34 Leu Mutation and the Risk of Venous Thrombosis

Martine Alhenc-Gelas

¹From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris

,

Jean-Luc Reny

¹From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris

,

Marie-Laurence Aubry

¹From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris

,

Martine Aiach

¹From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris

,

Joseph Emmerich

¹From the Service d’Hématologic Biologique A and Service des Maladies Vasculaires, Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université Rene Descartes, Paris

› Author Affiliations

Abstract

Full Text

References

References
1 Mikkola H, Syrjala M, Rasi V, Vahtera H, Hamalainen E, Peltonen L. Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on novel transcript levels. Blood 1994; 84: 517-25.
2 Kohler HP, Stickland MH, Ossel-Gerning N, Carter A, Mikkola H, Grant P. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
3 Elbaz A, Poirier O, Canaple S, Chedru F, Cambien F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
4 Trumbo TA, Maurer MC. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII Val 34 Leu mutation. J Biol Chem. 2000 (in press).
5 Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
6 Franco RF, Reitsma PH, Lourenco D, Maffei FH, Tavella MH, Araujo AG, Piccinato CE, Zago MA. Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost 1999; 81: 676-9.
7 Corral J, Gonzalez-Conejero R, Iniesta JA, Rivea J, Martinez C, Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 2000; 85: 293-7.
8 Rosendaal FR, Grant PJ, Ariens RAS, Poort SR, Bertina RM. Factor XIII Val34Leu, factor XIII antigen and activity levels and risk of venous thrombosis. Thromb Haemost 1999; 82: 508-9 (Suppl., abstract 1599).
9 Arnaud E, Nicaud V, Poirier O, Rendu F, Alhenc-Gelas M, Fiessinger JN, Emmerich J, Aiach M. Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol 2000; 20: 585-92.
10 Kangsadalampai S, Board PG. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 1998; 92: 2766-70.
11 Cucherat M, Boissel JP, Leizorovicz A, Haugh MC, Easy MA. a program for the meta-analysis of clinical trials. Computer Methods and Programs in Biomedicine 1997; 53: 187-90.